Provided by Tiger Fintech (Singapore) Pte. Ltd.

Genmab A/S

22.03
-0.8300-3.63%
Post-market: 22.030.00000.00%16:29 EDT
Volume:1.57M
Turnover:34.79M
Market Cap:13.57B
PE:12.00
High:22.43
Open:22.39
Low:22.02
Close:22.86
Loading ...

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Yesterday

Genmab Says Experimental Combination Trial Shows High Response Rates in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

MT Newswires Live
·
16 Jun

Genmab announces new results fom Phase 1b/2 EPCORE NHL-2 trial

TIPRANKS
·
16 Jun

Genmab A/S Stock Flat Thursday, Outperforms Market

Dow Jones
·
13 Jun

Genmab A/S Stock Rises Tuesday, Outperforms Market

Dow Jones
·
11 Jun

Genmab (GMAB) Receives a Buy from Truist Financial

TIPRANKS
·
04 Jun

Leerink Partners Sticks to Its Buy Rating for Genmab (GMAB)

TIPRANKS
·
04 Jun

Morgan Stanley Keeps Their Hold Rating on Genmab (GMAB)

TIPRANKS
·
03 Jun

Analysts’ Top Healthcare Picks: Genmab (GMAB), Omnicell (OMCL)

TIPRANKS
·
03 Jun

Sector Update: Health Care Stocks End Higher Late Afternoon

MT Newswires Live
·
03 Jun

Genmab Says New Trial Data Shows 'Encouraging Anti-Tumor Activity' for Rinatabart Sesutecan

MT Newswires Live
·
03 Jun

Genmab reports ‘encouraging anti-tumor activity’ for Rina-S in Phase 1/2 trial

TIPRANKS
·
03 Jun

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
03 Jun

RBC Cuts Price Target on Genmab to DKK2,000 From DKK2,300, Keeps Outperform Rating

MT Newswires Live
·
29 May

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
29 May

Genmab A/S Stock Rises Monday, Underperforms Market

Dow Jones
·
27 May

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
24 May

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), Genmab (GMAB) and Vir Biotechnology (VIR)

TIPRANKS
·
22 May

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
22 May

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
20 May